Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 17.14x is 433213% above its 5-year average of 0.00x, near the high end of its 5-year range (-22.79x–32.61x).
14.13% below its 12-month average of 19.96x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 30.26x.
INTEREST COVERAGE RATIO
17.14x
INTEREST COVERAGE RATIO AVG TTM
19.96x
INTEREST COVERAGE RATIO AVG 3Y
8.80x
INTEREST COVERAGE RATIO AVG 5Y
0.00x
INTEREST COVERAGE RATIO AVG 10Y
-7.14x
INTEREST COVERAGE RATIO AVG 15Y
-7.14x
INTEREST COVERAGE RATIO AVG 20Y
-238.32x
CURRENT VS TTM AVG
-14.13%
CURRENT VS 3Y AVG
+94.78%
CURRENT VS 5Y AVG
+433212.67%
CURRENT VS 10Y AVG
+340.22%
CURRENT VS 15Y AVG
+340.22%
CURRENT VS 20Y AVG
+107.19%
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+368.86%
vs the sector median at left
Rigel Pharmaceuticals, Inc.
Market Cap
$854.88M
Interest Coverage Ratio
17.14x
TTM Avg
19.96x
3Y Avg
8.80x
5Y Avg
0.00x
Market Cap
$852.84M
Interest Coverage Ratio
-5.18x
TTM Avg
6.05x
3Y Avg
536.48x
5Y Avg
359.36x
Market Cap
$869.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$840.18M
Interest Coverage Ratio
-80.18x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$872.01M
Interest Coverage Ratio
-9479.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$881.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals, Inc. (RIGL) | $854.88M | 17.14x | 19.96x | 8.80x | 0.00x |
| SI-BONE, Inc. (SIBN)vs › | $853.28M | -4.23x | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $852.84M | -5.18x | 6.05x | 536.48x | 359.36x |
| Alumis Inc. (ALMS)vs › | $843.04M | N/A | N/A | N/A | N/A |
| SL Science Holding Ltd (SLBT)vs › | $869.18M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $840.18M | -80.18x | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $838.84M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $872.01M | -9479.76x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $881.69M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $831.65M | N/A | N/A | N/A | N/A |
Interest Coverage
17.1x
Debt/Equity
0.09
Current Ratio
1.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 30.26x |
| 2026-03-31 | 8.29x |
| 2025-12-31 | 13.64x |
| 2025-09-30 | 15.01x |
| 2025-06-30 | 32.61x |
| 2025-03-31 | 6.89x |
| 2024-12-31 | 8.52x |
| 2024-09-30 | 6.82x |
| 2024-06-30 | 0.22x |
| 2024-03-31 | -3.72x |
| 2023-12-31 | 1.03x |
| 2023-09-30 | -2.35x |
| 2023-06-30 | -2.83x |
| 2023-03-31 | -10.57x |
| 2022-12-31 | 1.88x |
| 2022-09-30 | -22.28x |
| 2022-06-30 | -22.79x |
| 2022-03-31 | -21.79x |
| 2021-12-31 | -16.49x |
| 2021-09-30 | -15.02x |
| 2021-06-30 | -7.42x |
| 2021-03-31 | 86.09x |
| 2020-12-31 | -43.89x |
| 2020-09-30 | -32.12x |
| 2020-06-30 | -49.27x |
| 2020-03-31 | 148.08x |
| 2019-12-31 | -53.02x |
| 2019-09-30 | -1504.63x |
| 2011-12-31 | -8636.67x |
| 2011-09-30 | -4510.25x |
| 2011-06-30 | -3079.57x |
| 2011-03-31 | -1896.36x |
| 2010-12-31 | -936.62x |
| 2010-09-30 | 3357.20x |
| 2010-06-30 | 1079.12x |
| 2010-03-31 | -745.00x |
| 2009-12-31 | -678.43x |
| 2009-09-30 | -605.80x |
| 2009-06-30 | -434.75x |
| 2009-03-31 | -571.36x |
| 2008-12-31 | -1172.76x |
| 2008-09-30 | -899.58x |
| 2008-06-30 | -860.41x |
| 2008-03-31 | -611.60x |
| 2007-12-31 | -413.41x |
| 2007-09-30 | -364.75x |
| 2007-06-30 | -355.28x |
| 2006-09-30 | -124.77x |
| 2006-06-30 | -24.55x |
| 2006-03-31 | -151.03x |
| 2005-12-31 | -123.00x |
| 2005-06-30 | -194.31x |
| 2005-03-31 | -175.83x |
| 2004-12-31 | -196.08x |
| 2004-06-30 | -154.65x |
| 2004-03-31 | -139.57x |
| 2003-12-31 | -98.12x |
| 2003-09-30 | -75.15x |
| 2002-12-31 | -38.78x |
| 2002-09-30 | -47.42x |
